Mihir N. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mihir N. Patel has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
David Casarett
Duke University School of Medicine
3 shared publicationsJonathan Walter
Duke University School of Medicine
3 shared publicationsYvonne Acker
Duke University Health System
3 shared publications- Jamie Gollon
Business Transformation Office (J.G.), Duke University Health System, Durham, North Carolina, USA
2 shared publications - Jessica E. Ma
Department of Medicine Duke University School of Medicine Durham North Carolina USA
2 shared publications - Mark Sendak
Duke Institute for Health Innovation, Duke University, Durham, NC, USA
2 shared publications
Latest Publications
- 21 November 2025
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
Physician Characteristics Associated With Advance Care Planning After a Machine Learning-Based Nudge
Prognostic machine learning models can help identify patients in need of advance care planning (ACP) conversations. However, additional work is needed to understand which factors guide physicians’ comfort with and prioritization of ACP conversations, even after such nudges. In this exploratory secondary analysis of a cluster randomized trial, we examine the relationship between characteristics of internal medicine physicians (eg, training background and practice patterns) and likelihood of ACP conversation following notification by a mortality risk prediction machine learning model.
- 21 November 2025
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
Physician Characteristics Associated With Advance Care Planning After a Machine Learning-Based Nudge
Prognostic machine learning models can help identify patients in need of advance care planning (ACP) conversations. However, additional work is needed to understand which factors guide physicians’ comfort with and prioritization of ACP conversations, even after such nudges. In this exploratory secondary analysis of a cluster randomized trial, we examine the relationship between characteristics of internal medicine physicians (eg, training background and practice patterns) and likelihood of ACP conversation following notification by a mortality risk prediction machine learning model.
- 31 August 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 70 (6) , 602-612
Impact of Prognostic Notifications on Inpatient Advance Care Planning: A Cluster Randomized Trial
- 31 August 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 70 (6) , 602-612
Impact of Prognostic Notifications on Inpatient Advance Care Planning: A Cluster Randomized Trial
- 15 April 2025
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25 (8) , e570-e579.e4
Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis
- 15 April 2025
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25 (8) , e570-e579.e4
Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis
- 3 September 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 68 (6) , 539-547.e3
Machine Learning for Targeted Advance Care Planning in Cancer Patients: A Quality Improvement Study
- 3 September 2024
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 68 (6) , 539-547.e3
Machine Learning for Targeted Advance Care Planning in Cancer Patients: A Quality Improvement Study
- 25 November 2022
- Published by Elsevier in Endocrine Practice
- Vol. 28 (12) , S5-S6
#1322037: GLP-1 and IL6 in Human Adipose Tissue Beiging: Preliminary Results From a Crossover Clinical Trial
- 25 November 2022
- Published by Elsevier in Endocrine Practice
- Vol. 28 (12) , S5-S6
#1322037: GLP-1 and IL6 in Human Adipose Tissue Beiging: Preliminary Results From a Crossover Clinical Trial
- 1 December 2020
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 16 (12) , 803-809
Hospice Use Among Patients With Cancer: Trends, Barriers, and Future Directions
Patients with advanced cancer and their families frequently encounter clinical and logistical challenges related to end-of-life care. Hospice provides interdisciplinary and holistic care to meet patients’ biomedical, psychosocial, and spiritual needs in the last phases of life. Despite increasing general acceptance and use among patients with cancer, hospice remains underused. Underuse stems from ongoing misconceptions regarding hospice and its purpose, coupled with the rapid development of novel anticancer treatments, such as immunotherapies and targeted therapies, that have changed the landscape of possibilities. Furthermore, rapid evolutions in how end-of-life care is structured and reimbursed for will affect how oncology patients will intersect with hospice care. In this review, we explore the current and future challenges to greater integration of hospice care in the care of patients with advanced cancer and propose five recommendations as part of the path forward.
- 1 December 2020
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 16 (12) , 803-809
Hospice Use Among Patients With Cancer: Trends, Barriers, and Future Directions
Patients with advanced cancer and their families frequently encounter clinical and logistical challenges related to end-of-life care. Hospice provides interdisciplinary and holistic care to meet patients’ biomedical, psychosocial, and spiritual needs in the last phases of life. Despite increasing general acceptance and use among patients with cancer, hospice remains underused. Underuse stems from ongoing misconceptions regarding hospice and its purpose, coupled with the rapid development of novel anticancer treatments, such as immunotherapies and targeted therapies, that have changed the landscape of possibilities. Furthermore, rapid evolutions in how end-of-life care is structured and reimbursed for will affect how oncology patients will intersect with hospice care. In this review, we explore the current and future challenges to greater integration of hospice care in the care of patients with advanced cancer and propose five recommendations as part of the path forward.